Atlas FDA

Edwards Alterra Adaptive Prestent System

FDA premarket approval P200015/S022 · decided 2022-07-06

Approval details

PMA number
P200015
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Edwards Alterra Adaptive Prestent System
Generic name
Pulmonary valve prosthesis percutaneously delivered
Applicant
Edwards Lifesciences, LLC
Date received
2022-06-06
Decision date
2022-07-06
Days to decision
30 days
Decision code
OK30
Product code
NPV
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Changes to the Alterra prestent visual receiving inspection acceptance criteria and the austenite start temperature specification of the nitinol ingots used to manufacture the frame.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02